A carregar...
N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells
Non-small cell lung cancer (NSCLC) is a major subtype of lung cancer and is the most common and fatal cancer worldwide. Specific tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), such as gefitinib, have been effective in some NSCLC patients and are being used in the clinical se...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3196281/ https://ncbi.nlm.nih.gov/pubmed/22016830 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|